Latest Insider Transactions at Amicus Therapeutics, Inc. (FOLD)
This section provides a real-time view of insider transactions for Amicus Therapeutics, Inc. (FOLD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMICUS THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMICUS THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 08
2024
|
David Michael Clark Chief People Officer |
SELL
Open market or private sale
|
Direct |
8,726
-3.15%
|
$122,164
$14.0 P/Share
|
Jan 04
2024
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,296
-1.13%
|
$16,848
$13.44 P/Share
|
Jan 04
2024
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,692
-0.96%
|
$34,996
$13.44 P/Share
|
Jan 04
2024
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
10,659
-1.12%
|
$138,567
$13.44 P/Share
|
Jan 04
2024
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,368
-0.81%
|
$95,784
$13.44 P/Share
|
Jan 04
2024
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,380
-0.88%
|
$43,940
$13.44 P/Share
|
Jan 04
2024
|
Jeff Castelli Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,127
-0.83%
|
$40,651
$13.44 P/Share
|
Jan 03
2024
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,142
-6.65%
|
$105,846
$13.53 P/Share
|
Jan 03
2024
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,474
-4.38%
|
$539,162
$13.53 P/Share
|
Jan 03
2024
|
Jeff Castelli Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,083
-3.61%
|
$183,079
$13.53 P/Share
|
Jan 03
2024
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
108,417
-10.26%
|
$1,409,421
$13.53 P/Share
|
Jan 03
2024
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,650
-4.0%
|
$151,450
$13.53 P/Share
|
Jan 03
2024
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,397
-3.86%
|
$200,161
$13.53 P/Share
|
Jan 02
2024
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
15,833
-0.83%
|
$221,662
$14.24 P/Share
|
Jan 02
2024
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,833
+0.82%
|
$158,330
$10.45 P/Share
|
Jan 02
2024
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,452
-1.6%
|
$216,328
$14.24 P/Share
|
Jan 02
2024
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
153,810
+13.77%
|
-
|
Jan 02
2024
|
Jeff Castelli Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,038
-2.02%
|
$112,532
$14.24 P/Share
|
Jan 02
2024
|
Jeff Castelli Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,392
+12.6%
|
-
|
Jan 02
2024
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
144,628
+12.04%
|
-
|
Jan 02
2024
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,331
-2.13%
|
$88,634
$14.24 P/Share
|
Jan 02
2024
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,209
+13.95%
|
-
|
Jan 02
2024
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,985
-1.72%
|
$97,790
$14.24 P/Share
|
Jan 02
2024
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,131
+13.47%
|
-
|
Jan 02
2024
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
30,000
-8.06%
|
$420,000
$14.21 P/Share
|
Jan 02
2024
|
Ellen Rosenberg Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+7.46%
|
$150,000
$5.16 P/Share
|
Jan 02
2024
|
Simon N.R. Harford Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,392
+25.88%
|
-
|
Jan 02
2024
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,313
-1.06%
|
$18,382
$14.24 P/Share
|
Jan 02
2024
|
Samantha Prout Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,252
+16.94%
|
-
|
Dec 31
2023
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,356
-19.16%
|
$326,984
$14.19 P/Share
|
Dec 28
2023
|
Jeff Castelli Chief Development Officer |
SELL
Open market or private sale
|
Direct |
17,421
-4.87%
|
$243,894
$14.52 P/Share
|
Dec 27
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.44%
|
$70,000
$14.07 P/Share
|
Dec 27
2023
|
Ellen Rosenberg Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.42%
|
$25,000
$5.16 P/Share
|
Dec 26
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
30,000
-8.06%
|
$420,000
$14.0 P/Share
|
Dec 26
2023
|
Ellen Rosenberg Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+7.46%
|
$150,000
$5.16 P/Share
|
Dec 26
2023
|
Samantha Prout Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,659
-5.91%
|
$107,226
$14.0 P/Share
|
Dec 20
2023
|
Jeff Castelli Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,654
-0.46%
|
$21,502
$13.1 P/Share
|
Dec 19
2023
|
Jeff Castelli Chief Development Officer |
SELL
Open market or private sale
|
Direct |
17,500
-4.64%
|
$227,500
$13.25 P/Share
|
Dec 18
2023
|
Jeff Castelli Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,643
+2.24%
|
-
|
Dec 18
2023
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,212
+3.19%
|
-
|
Dec 18
2023
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
34,572
+3.65%
|
-
|
Dec 18
2023
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,940
+2.82%
|
-
|
Dec 18
2023
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
17,286
+2.09%
|
-
|
Dec 15
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,043
-0.68%
|
$72,516
$12.66 P/Share
|
Dec 01
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
11,702
-1.46%
|
$128,722
$11.08 P/Share
|
Dec 01
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,702
+1.43%
|
$23,404
$2.94 P/Share
|
Dec 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,043
-0.68%
|
$66,473
$11.08 P/Share
|
Nov 15
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,043
-0.67%
|
$60,430
$10.84 P/Share
|
Nov 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.67%
|
$60,440
$10.97 P/Share
|
Nov 01
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
11,700
-1.46%
|
$117,000
$10.97 P/Share
|